TK
Tinku Kumar Tyagi
About Tinku Kumar Tyagi
Data last updated:
Tinku Kumar Tyagi has 1 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Sponde Pharmaceutical Private Limited and Vnd Biogenics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vnd Biogenics Private Limited at ₹30,636 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 25 Nov 2024 | 2019 | ₹30,636 (FY 2024) | Active | |
| Director | 09 Sep 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tinku Kumar Tyagi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tinku Kumar Tyagi
Tinku Kumar Tyagi has 1 years in corporate governance. Holds Director and Additional Director roles. Currently with 2 companies, including Sponde Pharmaceutical Private Limited and Vnd Biogenics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Vnd Biogenics Private Limited at ₹30,636 (FY 2024).
Tinku Kumar Tyagi is associated with 2 companies as Director and Additional Director, including Vnd Biogenics Private Limited (₹30,636), Sponde Pharmaceutical Private Limited.
Tinku Kumar Tyagi has expertise in General Business.
Tinku Kumar Tyagi has 1 years in corporate governance.
By reported revenue, the largest current company of Tinku Kumar Tyagi is Vnd Biogenics Private Limited, with revenue of ₹30,636 (FY 2024).
Tinku Kumar Tyagi currently holds positions at 2 companies: Vnd Biogenics Private Limited (₹30,636), Sponde Pharmaceutical Private Limited.